Support to Patient Organisations 2016

Size: px
Start display at page:

Download "Support to Patient Organisations 2016"

Transcription

1 Support to Patient Organisations 2016 of Preparation March 2017 Country Disease Area Patient Advocacy Group Name Type of Support Description of support Cancer Campaigning Group (A coalition of a number of cancer charities). Financial support of the Cancer Campaigning Group, coalition of patient related organizations, to deliver plan of activity during , Cancer52 Sponsorship of PAG activities - Indirect Financial Support Use of a public affairs agency to facilitate the establishment of a rarer cancers working group looking at recommendations from Cancer Taskforce. 15, Cancer52 Direct financial support to help cover internal costs/ time spent on Rarer Cancers Working Group described above 3, Cancer52 Direct financial support to assist campaigns and public affairs activity in 2016/ , Action Bladder Cancer Sponsorship of PAG members to attend events and congresses Costs to support an Action Bladder Cancer Uk representative to attend Britain Against Cancer CML Support Group Financial support of the Chronic Myeloid Leukaemia Support Group to undertake its planned stakeholder activity in 2016 and to assist them to fine tune their website using developers. 10, Trust Sponsorship of Hep C Trust to establish a hepatitis c patient council and to support members of the council in advocating for change 6, Trust Sponsorship of Hep c Trust to provide secretariat support to HCV Action - a network connecting HCPs from across the patient pathway, sharing good practice in the prevention, testing and treatment of hepatitis C. 30, Trust Sponsorship of PAG activities - Indirect Financial Support Support given via public affairs agency to hold a pledge signing event in the Scottish Parliament 4,

2 Trust Sponsorship of PAG activities - Indirect Financial Support Sponsorship of Hep C Trust to support a series of awareness events about hepatitis C in the South Asian community 4, Kidney Cancer Sponsorship for KC to hold a day of information for patients in Edinburgh 2, Kidney Cancer Sponsorship for KC to hold a day of information for patients in Manchester 2, Kidney Cancer Sponsorship for KC to hold a day of information for patients in London 2, Kidney Cancer Financial support towards KC s survey of patients in 2016 in order to improve understanding and need. 2, Kidney Cancer Financial support towards a roundtable meeting with clinicians, the NHS and other policy makers to discuss the standard of treatment for kidney cancer across the 5, Kidney Cancer Financial support towards a new section on the KC website with information on standards of care across the, patient experience etc. 5, Leukaemia CARE Sponsorship of the Nurse Adviser Service nurse led helpline designed to support and advise leukaemia patients and their families 10, Liver 4 Life Sponsorship of PAG activities - Indirect Financial Support Support given via public affairs agency to hold a pledge signing event in the Scottish Parliament alongside the Hep C Trust 4, Lymphoma Association Financial sponsorship of Lymphoma Association National Patient Conference in ,

3 Lymphoma Association Financial sponsorship of research to update information for patients on Lymphoma Association website 2, Lymphoma Association support of a series of webinar programmes to help educate HCPs on how to manage symptoms of lymphoma 2, Lymphoma Association Financial sponsorship of a masterclass event aimed at clinical nurse specialists 2, Lymphoma Association Support towards a course aimed at upskilling/ updating consultants working in haematology 2, Lymphoma Association Sponsorship of parliamentary event designed to raise awareness of lymphoma amongst MPs as part of lymphoma awareness month 5, Macmillan Cancer Support Sponsorship of the Britain Against Cancer national conference, paid to Macmillan who are the organisers of the event 6, Melanoma Focus Sponsorship of PAG activities - Indirect Financial Support Support given via a public affairs agency to develop a patient decision aid to sit on Melanoma Focus' website. Additional support was provided as a secretariat to a meeting with melanoma clinicians to steer the content of the PDA. 35, Melanoma patient conference c.i.c Sponsorship of conference aimed at enabling melanoma patients to meet each other and leading Oncologists, Surgeons, etc. 10, Melanoma Sponsorship to update the online navigation tool on the Melanoma website 10, Melanoma Support given via a public affairs agency to update the Melanoma Dashboard with 2016 data incidence, mortality etc. 13, Sponsorship of PAG activities - Indirect Financial Support

4 Melanoma Sponsorship of PAG activities - Indirect Financial Support Support given via a public affairs agency to assist the Melanoma Taskforce - a group of melanoma PAGs headed by Melanoma - with their stakeholder activity in 2016 and research into patient outcomes. 22, Melanoma Partnership joint PAG/BMS - Indirect financial support Support given via a public affairs agency to assist Melanoma hold a disease awareness roundtable in the Scottish Parliament 12, Myfanwy Townsend Melanoma Research Fund Support of the campaign Watch his Back! - The Gardeners Sun Safety Code 10, General Patients Association Fee associated with becoming corporate members of the Patients Association over the next 12 months. Funds support the work of the organisation. 10, General Patients Association Use of PAG member as a speaker at a non-promotional advisory board CEO, Katherine Murphy Chaired the Transforming the Cycle in Cancer Care meeting in December , Rarer Cancers Foundation Financial support of the Rarer Cancers Foundation to deliver plan of public affairs activity during , General Specialised Healthcare Alliance Financial support of coalition of patient related organizations to deliver plan of activity during , The Karen Clifford Skcin cancer charity Sponsorship to ensure the continuation of the Sun Safe Schools and Sun Safe Workplaces schemes. 10, The Roy Castle Lung Cancer Foundation Partnership joint PAG/BMS - Indirect financial support Joint project to host a lung cancer awareness roundtable in Westminster. Support is given in the form of public affairs agency support. 12, Trust Sponsorship for PR agency services PR agency support for development of infographics for use by the Trust in media activities/campaigns 5,

5 CV Thrombosis Atrial Fibrillation Awareness Week in November Honorarium or a Thrombosis representative to speak at an Atrial Fibrillation Aware Week Who Are You Working For? Event at BMS HQ Roy Castle Lung Cancer Foundation (RCLCF) Expenses for media advisory board participation Payment of travel and accommodation expenses for two RCLCF representatives for their participation in a media advisory board, providing the patient advocacy perspective on behalf of RCLCF Lung Cancer Coalition Sponsorship of PAG Activities - Financial Support Sponsorship of PAG activity , CV Anticoagulation Europe Use of PAG member as a speaker at a non promotional meeting/advisory board The BMS-Pfizer Alliance paid for an Anticoagulation Europe staff member to attend an advisory board meeting* * shown was BMS s contribution to the total payment from the BMS-Pfizer CV Anticoagulation Europe Partnership Joint PAG/BMS - Financial The BMS-Pfizer Alliance paid for the advisory input of Anticogulation Europe in a BMS-Pfizer Allianceled disease awareness campaign.* * shown was BMS s contribution to the total payment from the BMS-Pfizer 8, CV Anticoagulation Europe Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance made a charitable donation towards the product cost of an animation on venous thromboembolism* * shown was BMS s contribution to the total payment from the BMS-Pfizer 4, CV Anticoagulation Europe Use of PAG member as a speaker at a non promotional meeting/advisory board CV Anticoagulation Europe Partnership Joint PAG/BMS - Financial The BMS-Pfizer Alliance paid for an Anticoagulation Europe staff member to take part in an advisory board meeting. This was a late payment for an activity which took place in 2014 and was claimed by the organisation in 2016.* * shown was BMS s contribution to the total payment from the BMS-Pfizer The BMS-Pfizer Alliance paid for an Anticoagulation Europe staff member to speak at a BMS-Pfizer Alliance internal meeting* * shown was BMS s contribution to the total payment from the BMS-Pfizer CV Arrhythmia Alliance Partnership Joint PAG/BMS - Financial The BMS-Pfizer Alliance paid for the advisory input of the Arrhythmia Alliance in a BMS-Pfizer Allianceled disease awareness campaign.* * shown was BMS s contribution to the total payment from the BMS-Pfizer 1, CV Arrhythmia Alliance Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance paid for a stand at a Cardiac Update meeting for healthcare professionals organised by the Arrhythmia Alliance.* * shown was Pfizer s contribution to the total payment from the BMS-Pfizer

6 CV Atrial Fibrillation Association Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance sponsored the Atrial Fibrillation Association to provide the Secretariat to the All Party Parliamentary Group on Atrial Fibrillation for This was paid in 2016.* * shown was BMS s contribution to the total payment from the BMS-Pfizer 10, CV Atrial Fibrillation Association Partnership Joint PAG/BMS - Financial The BMS-Pfizer Alliance paid for the advisory input of the Atrial Fibrillation Association in a BMS-Pfizer Alliance-led disease awareness campaign.* * shown was BMS s contribution to the total payment from the BMS-Pfizer 8, CV Atrial Fibrillation Association Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance made a charitable donation towards the Atrial Fibrillation Association's AF Aware Week activities* * shown was Pfizer s contribution to the total payment from the BMS- Pfizer 5, CV Atrial Fibrillation Association Use of PAG member as a speaker at a non promotional meeting/advisory board The BMS-Pfizer Alliance paid for an Atrial Fibrillation Association staff member to attend an advisory board meeting, which took place in the Netherlands* * shown was BMS s contribution to the total payment from the BMS-Pfizer CV Different Strokes Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance made a charitable donation towards the publication of the Different Strokes member newsletter in This was paid in 2016* * shown was BMS s contribution to the total payment from the BMS-Pfizer 2, CV Different Strokes Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance made a charitable donation towards the publication of the Different Strokes member newsletter* * shown was BMS s contribution to the total payment from the BMS- Pfizer 2, CV Stroke Association Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance sponsored the Stroke Forum meeting, which was organised by the Stroke Association and took place in December 2015* * shown was BMS s contribution to the total payment from the BMS-Pfizer 15, CV Stroke Association Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance paid for two delegate passes at the Stroke Forum meeting, which was organised by the Stroke Association and took place in December 2015* * shown was BMS s contribution to the total payment from the BMS-Pfizer CV Stroke Association Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance made a donation in support of the Stroke Association's campaign on atrial fibrillation* * shown was BMS s contribution to the total payment from the BMS-Pfizer 15, CV Stroke Association Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance sponsored the Stroke Association's Northern Ireland conference for healthcare professionals and in return was able to set up a stand at the meeting* * shown was BMS s contribution to the total payment from the BMS-Pfizer

7 CV Thrombosis Sponsorship of PAG activities- Financial Support The BMS-Pfizer Alliance sponsored a series of meetings for patients and healthcare professionals organised by Thrombosis as part of National Thrombosis Week * shown was BMS s contribution to the total payment from the BMS-Pfizer 1, Myeloma Use of PAG member as a speaker at a non promotional meeting/advisory board Honoraria/Out of pocket expenses for Myeloma advisory board at 2015 ASH Conference (Orlando, FL, USA) Myeloma Use of PAG member as a speaker at a non promotional meeting/advisory board Honoraria/out of pocket expenses for 2016 GOAL meeting during ASCO (Chicago, IL, USA) Roy Castle Lung Cancer Foundation (RCLCF) Use of PAG member as a speaker at a non promotional meeting/advisory board Honoraria for GOAL meeting during ASCO (Chicago, IL, USA) Cancer Research Sponsorship of PAG activities Sponsorship of 2015 National Cancer Research Institute conference, including stand space and medical symposium 2,

8 Support to patient organisations 2015 Provided by Bristol-Myers Squibb, overseas affiliates, Europe head office, Corporate head office: of preparation March 2016 Revised Jan 2017 * All amounts shown are Bristol-Myers Squibb's contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibbb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases Country Disease Area Patient Advocacy Groups Name Type of Support Description of support Description of the Contracted services (if applicable) HCV Trust Part Sponsorship of HCV Action's 2015 policy and Public Affairs programme. 23,000 HCV Trust Sponsorship of HCV in the South Asian Community Awareness and Testing event in Glasgow 750 HCV Trust Sponsorship of Patient Advocay and Government affairs activities in Scotland. 2,500 HCV Trust Support of Trust Activities around World Hepatitis Day 2,250 HCV Trust Use of a PAG menber as a speaker - Consultancy agreement BMS Internal World Hepatitis day Lunch and Learn Presentation on the Hep C patient expereince 300 HCV Coalition Sponsorship of the Coalition's Q3 & 4 Public Affairs Activity 20,000 HCV Haemophilia Scotland Part Sponsorship of Patient conference 1,175 HCV National Aids Map Part sponsorship of InfoHep 10,000 HCV British Liver Trust Sponsorship of BLT to execute disease awareness activities at BMS Internal World Hepatitis day Lunch and Learn 500 HCV Liver 4 Life Financial support Financial support for accommodation and travel for participation in hepatitis C radio day 256 HCV Liver4Life Partnership Joint PAG/BMS - Indirect Financial Support Delivery of parliamentary event "No Patient Left Behind" via public affairs agency support 9,500 British Lung Foundation Sponsorship of PAG Activities - Indirect Support Indirect support via public affairs agency for support relating to a Lung Cancer Working Group on emergency diagnosis 45,038 Specialised Healthcare Alliance Part Sponsorship of 2015 workplan 24,000 - Myeloma - Myeloma - Myeloma Myeloma Use of a PAG menber as a speaker - Fee for service BMS Internal Myeloma Awareness Week Lunch and Learn Travel expenses only - undisclosed Myeloma Patient Pathway 10,000 Myeloma Patient Elicitation 35,000 - Myeloma Basil Skyers Myeloma Foundation Partnership Joint PAG/BMS - Indirect Financial Support Partnership between BMS and Basil Skyers Myeloma Foundation to develop solutions to the recommendations within the Listen Up! report. Specifically: the organisation of a roundtable with key stakeholders 18,666 - RCC James Whale Fund for Kidney Cancer Patient Pathway 7,500 - RCC James Whale Fund for Kidney Cancer Patient information Days 12,000 - RCC James Whale Fund for Kidney Cancer Fee for service Patient Survey 2,000 - CML CML Support Use of a PAG menber as a speaker at a non-promotional meeting BMS Internal World CML Day presentation 300 CML Support Sponsorship of PAG Activities - Financial Support Sponsorship of PAG activity ,000 Leukamia Care Sponsorship of PAG Activities - Financial Support Sponsorship of PAG activity ,000 Specialised Healthcare Alliance Sponsorship of PAG Activities - Financial Support Sponsorship of PAG activity ,000 Rarer Cancers Foundation Sponsorship of PAG Activities - Financial Support Sponsorship of PAG activity ,000 Myfanwy Townsend Melanoma Research Fund Sponsorship of PAG Activities - Financial Support Sponsorship of PAG activity ,000 Roy Castle Lung Cancer Foundation Sponsorship of PAG Activities - Financial Support Sponsorship of PAG activity ,420 Macmillan Cancer Support Sponsorship of PAG Activities - Financial Support Sponsorship of Britiain Against Cancer conference ,900 Cancer Campaigning Group Sponsorship of PAG Activities - Financial Support Sponsorship of PAG activity ,000 Lung Cancer Coalition Sponsorship of PAG Activities - Financial Support Sponsorship of PAG activity ,000 Melanoma Sponsorship of PAG Activities - Indirect Support Indirect support via public affairs agency for melanoma patient experience survey 11,936 Melanoma Sponsorship of PAG Activities - Indirect Support Indirect support via public affairs agency for melanoma stakeholder engagement 50,000 Melanoma Sponsorship of PAG Activities - Indirect Support Indirect support via public affairs agency for launch of Melanoma Dashboard 8,500

9 Melanoma Sponsorship of PAG Activities - Indirect Support Partnership to update melanoma dahsboard online tool 38,727 Roy Castle Lung Cancer Foundation Sponsorship of PAG Activities - Indirect Support Indirect support via public affairs agency for lung cancer awareness events 15,000 Roy Castle Lung Cancer Foundation Partnership of PAG / BMS - Non-Financial Partnership to deliver cancer awareness event in Parliament 4,400 Melanoma Partnership of PAG / BMS - Non-Financial Partnership to deliver cancer awareness event in Parliament 4,400 James Whale Fund for Kidney Cancer Partnership of PAG / BMS - Non-Financial Partnership to deliver cancer awareness event in Parliament 4,400 Kidney Cancer Scotland Partnership of PAG / BMS - Non-Financial Partnership to deliver cancer awareness event in Parliament 2,200 Cardiovascular Anticoagulation Europe Sponsorship of PAG Activities - Financial Support Cardiovascular Anticoagulation Europe Use of PAG member as a speaker at a non-promotional meeting/advisory board Cardiovascular Anticoagulation Europe Partnership Joint PAG/BMS - Financial Support The BMS-Pfizer Alliance sponsored Anticoagulation Europe to provide the Secretariat to the All- Party Parliamentary Group on Thrombosis for the second half of The BMS-Pfizer Alliance paid a consultancy fee for the participation of an Anticoagulation Europe staff member in a BMS-Pfizer Alliance European Advisory Board meeting which took place in the. The BMS-Pfizer Alliance paid for the advisory input of Anticoagulation Europe in a BMS-Pfizer Alliance-led disease awareness campaign 7, , Cardiovascular Anticoagulation Europe Sponsorship of PAG Activities - Financial Support The BMS-Pfizer Alliance sponsored Anticoagulation Europe to provide the Secretariat to the All- Party Parliamentary Group on Thrombosis for , Cardiovascular Arrhythmia Alliance Partnership Joint PAG/BMS - Financial Support The BMS-Pfizer Alliance paid for the advisory input of the Arrhythmia Alliance in a BMS-Pfizer Alliance-led disease awareness campaign 2, Cardiovascular Arrhythmia Alliance Sponsorship of PAG Activities - Financial Support The BMS-Pfizer Alliance sponsorsed the Heart Rhythm Congress 2015 which was organised by the Arrhythmia Alliance 16, Cardiovascular Arrhythmia Alliance Sponsorship of PAG Activities - Financial Support The BMS-Pfizer Alliance made a charitable donation towards a local diseease awarenes project organised by the Arrhythmia Alliance 7, Cardiovascular Arrhythmia Alliance Sponsorship of PAG Activities - Financial Support The BMS-Pfizer Alliance paid for two stands at two Cardiac Update meetings for healthcare professionals organised by the Arrhythmia Alliance Cardiovascular Atrial Fibrillation Association Sponsorship of PAG Activities - Financial Support Cardiovascular Atrial Fibrillation Association Use of PAG member as a speaker at a non-promotional meeting/advisory board Cardiovascular Atrial Fibrillation Association Sponsorship of PAG Activities - Financial Support Cardiovascular Atrial Fibrillation Association Sponsorship of PAG Activities - Financial Support Cardiovascular Atrial Fibrillation Association Sponsorship of PAG Activities - Financial Support Cardiovascular Stroke Association Use of PAG member as a speaker at a non-promotional meeting/advisory board The BMS-Pfizer Alliance sponsored the Atrial Fibrillation Association to provide the Secretariat to the All-Party Parliamentary Group on Atrial Fibrillation for This was paid in The BMS-Pfizer Alliance paid a consultancy fee for the participation of an Atrial Fibrillation Association staff member in a BMS-Pfizer Alliance European Advisory Board meeting which took place in the. The BMS-Pfizer Alliance paid for the advisory input of the Atrial Fibrillation Association in a BMS- Pfizer Alliance-led disease awareness campaign The BMS-Pfizer Alliance made a charitable donation to the AF Association to cover the re-print costs of the GRASP Action Plan on atrial fibrillation (250 copies), published by the AF Association. The BMS-Pfizer Alliance sponsored a summit meeting on anticoagulation jointly organised by the Atrial Fibrillation Association and Anticoagulation Europe on behalf of the All Party Parliamentary Group on AF and the All Party Parliamentary Group on Thrombosis The BMS-Pfizer Alliance engaged the Stroke Association to provide expert speakers at three BMS Pfizer Regional Meetings on Stroke Prevention in Atrial Fibrillation 15, , , , Cardiovascular Stroke Association Sponsorship of PAG Activities - Financial Support The BMS-Pfizer Alliance sponsored the Stroke Association's Northern Ireland Stroke Conference Annual Update Cardiovascular Thrombosis Sponsorship of PAG Activities - Financial Support The BMS-Pfizer Alliance sponsored Thrombosis 's National Thrombosis Week educational meeting 1,250.00

10 Support to patient organisations 2014: (SPONSORSHIP) Provided by Bristol-Myers Squibb, overseas affiliates, Europe head office, Corporate head office: of preparation March 2015 NO15NP *All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable) Total Paid Type of Support Description of the Support HIV National AIDS Trust Sponsorship of NATs Policy Network activities related to the NHS England 14,000 HIV Clinical Reference Group. HIV National Aids Map Part sponsorship of HIV - Women and Pregnancy leaflet update and 10,000 production HCV Hepatitis Scotland Co-Sponsorship of Patient Conference 2,500 HCV Trust Sponsorship of PAG activities - Indirect financial Support BMS will provide indirect financial support in the form of the time of Insight Public Affairs to assist in this activity. Under the direction of HCV Action (a sub group of Hep C Trust), Insight PA will audit JSNAs and HWB Strategies to determine the level of priority assigned to Hep C 4,000 HCV Trust Financial support for HCV Action Group 22,000 HCV Trust Partnership Joint PAG/BMS - Financial Financial support for radio day 418 HCV Homeless Link Partnership Joint PAG/BMS - Indirect Financial Support Sponsorship of a policy task force via indirect financial support (up to the 20,738 value of 35,000)* in the form of the time of Insight Public Affairs who will provide secetariat functions. In practice support to the value of 20,738 was provided Rarer Cancers foundation Financial support for Industry Reference Group 18,000 Melanoma Financial support for the provision of patient support activities 15,000 SKCIN Sponsorship of PAG activities - Indirect financial Support Indirect financial support for communication and stakeholder activities 12,500 Cancer 52 Financial support for stakeholder outreach programme 10,000 Cancer Campaigning Group Financial support for government affairs activities 10,000 CML Support Financial support for stakeholder outreach programme 10,000 Leukeamia Care Financial support for nurse conference 10,000 Melanoma Sponsorship of PAG activities - Indirect financial Support Indirect support for the development of a melanoma dashboard 80,940 Europe Teenage Cancer trust Financial support for their conference 3,000 Europe Melanoma Sponsorship of PAG activities - Indirect financial Support Indirect financial support for stakeholder outreach programme 16,196 Melanoma Sponsorship of PAG activities - Indirect financial Support Indirect support for melanoma meeting 7,418 Melanoma Sponsorship of PAG activities - Indirect financial Support Indirect financial support for communication and stakeholder activities 12,500 Rheumatoid Arthritis National Rheumatoid Arthritis Society Part sponsorship of RA Awareness Week 3,500 Rheumatoid Arthritis National Rheumatoid Arthritis Society Part sponsorship of NRAS Annual Patient Conference 1,500 Rheumatoid Arthritis Arthritis Care Sponsorship of Regional Patient Self-Management Programme 3,759 Cardiovascular AF Association * The BMS-Pfizer Alliance made a payment towards the costs of AF 30,000 Association s regional patient education programme on AF Cardiovascular Anticoagulation Europe * The BMS-Pfizer Alliance provided funding to enable Anticoagulation Europe to provide the Secretariat to the All-Party Parliamentary Group on Thrombosis for the first half of 2014 Cardiovascular Anticoagulation Europe * The BMS-Pfizer Alliance made a payment towards the costs of Anticoagulation Europe s regional patient education meetings 7,500 9,750 Cardiovascular Arrhythmia Alliance * The BMS-Pfizer Alliance paid for sponsorship of the Arrhythmia Alliance s Cardiac Update meeting series for healthcare professionals in 2013 and 2014 (2013 payment made in 2014) Cardiovascular Arrhythmia Alliance * The BMS-Pfizer Alliance paid for sponsorship of the Arrhythmia Alliance s 10th Anniversary parliamentary event in Westminster Cardiovascular Arrhythmia Alliance * The BMS-Pfizer Alliance made a payment towards the Arrhythmia Alliance s organisation of a launch event in the EU Parliament in Brussels, and European-wide roll-out, of a report on Atrial Fibrillation in Europe Cardiovascular Stroke Association * The BMS-Pfizer Alliance made a payment towards the cost of the Stroke Association s Ask First campaign, an educational campaign on atrial fibrillation aimed at healthcare professionals, patients and the general public Cardiovascular Stroke Association * The BMS-Pfizer Alliance paid for a sponsorship package at the 2014 Stroke Forum, organised by the Stroke Association 10, ,750 20,000 8,500 Sub total 407,644

11 Patient organisations engaged to provide significant contracted services 2014: (FEE FOR SERVICE) Provided by Bristol-Myers Squibb, overseas affiliates, Europe head office, Corporate head office: of preparation March 2015 NO15NP *All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Limited), which was 50% in all cases Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable) Description of the Support Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance Advisory Board meeting which took place in the Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance Advisory Board meeting which took place in the Europe Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance Advisory Board meeting which took place in the Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honorarium for the participation of an AF Association staff member in a BMS-Pfizer Alliance Advisory Board meeting which took place in the Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honoraria for preparation time and participation of an AF Association staff member in BMS-Pfizer Alliance Patient Group Summit which took place in Europe Cardiovascular AF Association Use of a PAG member as a speaker at a non-promotional meeting Travel* * The BMS-Pfizer Alliance paid expenses to one AF Association staff member in relation to their participation in a BMS-Pfizer Alliance Patient Group Summit which took place in Europe: Flights = / Accommodation = / Transfers = Cardiovascular Stroke Association Use of a PAG member as a speaker at a non-promotional meeting Fee for Service* * The BMS-Pfizer Alliance paid an honorarium for the participation of a Stroke Association staff member in a BMS-Pfizer organised radio day on atrial fibrillation Cardiovascular Stroke Association Advocacy Meetings Fee for Service* *The BMS-Pfizer Alliance contracted the Stroke Association to provide a speaker at four BMS-Pfizer Alliance organised regional meetings for healthcare professionals, commissioners and policymakers on atrial fibrillation Total Paid , Sub total 5,268 Type of Support Grants Donations Sponsorship of PAG activities - Non-financial Support Sponsorship of PAG activities - Indirect financial Support Partnership Joint PAG/BMS - Financial Partnership Joint PAG/BMS - Non-financial Partnership Joint PAG/BMS - Indirect Financial Support Sponsorship of PAG members to attend events and congresses Advocacy Meetings Use of a PAG member as a speaker at a non-promotional meeting Advisory Board

Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable)

Country Disease Area Patient Advocacy Group Name Description of the Contracted Services (when applicable) Support to patient organisations 2014: (SPONSORSHIP) *All amounts shown are Bristol-Myers Squibb s contribution to the total payment from the BMS-Pfizer Alliance (an alliance between Bristol-Myers Squibb

More information

Bristol-Myers Squibb (UK & Ireland) Publication of Data on Patient Advocacy Groups - for the period 01 January to 31 December 2017

Bristol-Myers Squibb (UK & Ireland) Publication of Data on Patient Advocacy Groups - for the period 01 January to 31 December 2017 Bristol-Myers Squibb ( & Ireland) Publication of Data on Patient Advocacy Groups - for the period 01 January to 31 December 2017 Interaction Country Disease Area Patient Advocacy Group Name Contracted

More information

DECEMBER 2012 PAYMENTS

DECEMBER 2012 PAYMENTS In order to align with the financial reporting periods of the majority of organisations, from this year we are disclosing payments by calender year, rather than by our financial reporting year (which runs

More information

During 2012, Pfizer supported Age Concern with the following:

During 2012, Pfizer supported Age Concern with the following: Action on Pain Action on Pain provides advice and support to people living with pain and strives to raise the profile of pain among politicians, the NHS and healthcare professionals. During 2012, Pfizer

More information

In 2017, we are proud to have supported the following patient organisations:

In 2017, we are proud to have supported the following patient organisations: SERVIER LABORATORIES LTD YEAR ENDED 31 ST DECEMBER 2017 PATIENT ORGANISATIONS In 2017, we are proud to have supported the following patient organisations: Lymphoma Association The Lymphoma Association

More information

Grants, Donations and Payments PATIENT ORGANISATIONS

Grants, Donations and Payments PATIENT ORGANISATIONS Z Grants, Donations and Payments 2013 - PATIENT ORGANISATIONS Name of Beneficiary Organization Program/Project Description Support Type Country Currency Amount Arthritis and Musculoskeletal Alliance (ARMA)

More information

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016 Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016 Please note that all information in this document is also disclosed in the overall report on Pfizer

More information

Pfizer s 2017 patient organisation disclosure report

Pfizer s 2017 patient organisation disclosure report Executive summary Pfizer s 2017 patient organisation disclosure report Pfizer is committed to working transparently with patient organisations. For more information about how and why Pfizer works with

More information

ABBVIE LTD ABPI DISCLOSURE REQUIREMENTS ON FINANCIAL SUPPORT FOR PATIENT ORGANISATIONS FOR FINANCIAL YEAR 2016

ABBVIE LTD ABPI DISCLOSURE REQUIREMENTS ON FINANCIAL SUPPORT FOR PATIENT ORGANISATIONS FOR FINANCIAL YEAR 2016 ABBVIE LTD ABPI DISCLOSURE REQUIREMENTS ON FINANCIAL SUPPORT FOR PATIENT ORGANISATIONS FOR FINANCIAL YEAR 2016 Provided To Patient Organisations (2016 ABPI Clauses 27.7& 27.8) Addaction 35,000.00 Event

More information

Program/Project Description. MSD paid Arthritis and Musculoskeletal Alliance for annual Corporate Membership

Program/Project Description. MSD paid Arthritis and Musculoskeletal Alliance for annual Corporate Membership Z Grants, Donations and s 2013 - PATIENT ORGANISATIONS United Kingdom Name of Beneficiary Organization Arthritis and Musculoskeletal Alliance (ARMA) Program/Project Description MSD paid Arthritis and Musculoskeletal

More information

Total Payment for sponsored attendances by Healthcare Professionals: 182,677 ( 153,923 in 2013)

Total Payment for sponsored attendances by Healthcare Professionals: 182,677 ( 153,923 in 2013) Gilead Sciences Ltd. 280 High Holborn London WC1V 7EE 31st March 2015 Relationships with Healthcare Professionals in the United Kingdom Gilead Sciences makes payments to Healthcare Professionals for consultancy

More information

The next steps

The next steps Greater Manchester Hepatitis C Strategy The next steps 2010-2013 Endorsed by GM Director of Public Health group January 2011 Hepatitis Greater Manchester Hepatitis C Strategy 1. Introduction The Greater

More information

Sustain and succeed When? Wednesday 25 April 2012 Time? 10am pm Where? Central London

Sustain and succeed When? Wednesday 25 April 2012 Time? 10am pm Where? Central London Pfizer thinkspace is a series of free development workshops for patient organisations. Each of the sessions is designed to offer a quality learning experience delivered in a participative style, by Pfizer

More information

CROSS-PARTY GROUP REGISTRATION FORM

CROSS-PARTY GROUP REGISTRATION FORM CROSS-PARTY GROUP REGISTRATION FORM NAME OF CROSS-PARTY GROUP Cross-Party Group on Cancer PURPOSE OF THE GROUP AND PROPOSED DISCUSSION TOPICS 1. Please state the purpose of the Group. 2. Please also provide

More information

All Party Parliamentary Group on Cancer

All Party Parliamentary Group on Cancer September 2010 Dear Colleague BRITAIN AGAINST CANCER 2010 A new cancer strategy, a new NHS making it work I am writing to invite you to participate in the Britain Against Cancer Conference 2010, hosted

More information

Pfizer Support to European and International Patient Organisations in 2008

Pfizer Support to European and International Patient Organisations in 2008 Pfizer Support to European and International Patient Organisations in 2008 The EFPIA Code on Relationships between the Pharmaceutical Industry and Patient Organisations came into force across Europe on

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA215; Pazopanib for the first line treatment of advanced

More information

SCOTTISH PARLIAMENTARY EVENT 12 TH NOVEMBER 2014

SCOTTISH PARLIAMENTARY EVENT 12 TH NOVEMBER 2014 SCOTTISH PARLIAMENTARY EVENT 12 TH NOVEMBER 2014 INTRODUCTION The Specialised Healthcare Alliance (SHCA) is a coalition of over 100 patient-related organisations, supported by 14 corporate members, which

More information

Relationships with Healthcare Organisations, Patient Organisations and Healthcare Professionals

Relationships with Healthcare Organisations, Patient Organisations and Healthcare Professionals Relationships with Healthcare s, Patient s and Healthcare Professionals Healthcare and Patient s CSL Behring makes available a number grants to Healthcare and Patient s. Grants are made in accordance with

More information

British Association of Stroke Physicians Strategy 2017 to 2020

British Association of Stroke Physicians Strategy 2017 to 2020 British Association of Stroke Physicians Strategy 2017 to 2020 1 P age Contents Introduction 3 1. Developing and influencing local and national policy for stroke 5 2. Providing expert advice on all aspects

More information

WHO Framework Convention on Tobacco Control. Submission from the National Heart Forum (UK)

WHO Framework Convention on Tobacco Control. Submission from the National Heart Forum (UK) WHO Framework Convention on Tobacco Control Submission from the National Heart Forum (UK) Introduction The UK s National Heart Forum (NHF) welcomes the opportunity to contribute to the development of the

More information

Tackling atrial fibrillation the health economics evidence

Tackling atrial fibrillation the health economics evidence Tackling atrial fibrillation the health economics evidence Professor Gary Ford,CBE Chief Executive Officer, Oxford Academic Health Science Network Consultant Stroke Physician, Oxford University Hospitals

More information

Report to the Board of Directors April Annual Gifts and Hospitality Report for the period 1st April st March 2014

Report to the Board of Directors April Annual Gifts and Hospitality Report for the period 1st April st March 2014 Report to the Board of Directors April 2014 Annual Gifts and Hospitality Report for the period 1st April 2013 31st March 2014 The Trust s policy on the Receipt of Hospitality, Gifts, Payment and Commercial

More information

Variations in Melanoma Survey

Variations in Melanoma Survey Variations in Melanoma Survey CONTENTS 1) Overview: Melanoma Taskforce Meeting 22 nd November 2011 3 2) Recommended Next Steps 3 3) Discussion 4 a. Public Awareness b. GP Education c. Appropriate referral

More information

Constitution, Terms of Reference and Standing Orders

Constitution, Terms of Reference and Standing Orders ASSOCIATION FOR RESPIRATORY TECHNOLOGY & PHYSIOLOGY ARTP SLEEP APNOEA CONSORTIUM (ARTP SAC) FINAL VERSION JULY 2008 Constitution, Terms of Reference and Standing Orders 1. INTRODUCTION 1.1 Since 2004 the

More information

WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE

WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE EXECUTIVE SUMMARY Incidence of cancer is rising, with one in two people born after 1960 expected to be diagnosed

More information

Terms of Reference for the Clinical Board of the Pumping Marvellous Foundation

Terms of Reference for the Clinical Board of the Pumping Marvellous Foundation Terms of Reference for the Clinical Board of the Pumping Marvellous Foundation The terms of reference for the Clinical Board of the Pumping Marvellous Foundation are in place to ensure a clear understanding,

More information

Membership of cirrhosis guideline Committee

Membership of cirrhosis guideline Committee Membership of cirrhosis guideline Committee The Committee will operate as an advisory Committee to NICE s Board, developing a guideline on cirrhosis. The terms of reference and standing orders for the

More information

Living with Leukaemia Leukaemia Care Patient Experience Survey (2016)

Living with Leukaemia Leukaemia Care Patient Experience Survey (2016) Living with Leukaemia Leukaemia Care Patient Experience Survey (2016) Zack Pemberton-Whiteley CML Horizons - Warsaw 5 th May 2018 Campaigns and Advocacy Director, Leukaemia Care (UK) CML Advocates Network

More information

The HIV Prevention England programme: what s next? Cary James May 2016

The HIV Prevention England programme: what s next? Cary James May 2016 The HIV Prevention England programme: what s next? Cary James May 2016 Summary Programme objectives Campaign evolution Sector development Structure and governance Support for HIV prevention system Communication

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA96; Adefovir dipivoxil and peginterferon alfa-2a for

More information

CROSS-PARTY GROUP ANNUAL RETURN

CROSS-PARTY GROUP ANNUAL RETURN CROSS-PARTY GROUP ANNUAL RETURN NAME OF CROSS-PARTY GROUP Cross-Party Group in the Scottish Parliament on Palliative Care DATE GROUP APPROVED 29 June 2011 DATE ANNUAL RETURN SUBMITTED 20 June 2012 GROUP

More information

The History of the national Lung Cancer Forum for nurses

The History of the national Lung Cancer Forum for nurses The History of the national Lung Cancer Forum for nurses Following the Calman hine report in 1995 (Doh), which emphasised the potential value of site-specific specialist nurses in improving the care cancer

More information

HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report

HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report About HCV Action HCV Action is a network, co-ordinated by The Hepatitis C Trust, that brings together health professionals

More information

A PATIENT AND PUBLIC INVOLVEMENT STRATEGY RESEARCH DESIGN SERVICE NORTH WEST. November 2011 Version 2.0

A PATIENT AND PUBLIC INVOLVEMENT STRATEGY RESEARCH DESIGN SERVICE NORTH WEST. November 2011 Version 2.0 A PATIENT AND PUBLIC INVOLVEMENT STRATEGY RESEARCH DESIGN SERVICE NORTH WEST November 2011 Version 2.0 Page 1 of 8 Our aim The overall aim of the NIHR Research Design Service North West (NIHR RDS NW) in

More information

Report to the GAVI Alliance Board 7-8 July 2011

Report to the GAVI Alliance Board 7-8 July 2011 Report to the GAVI Alliance Board 7-8 July 2011 Subject: Report of: Authored by: GAVI Matching Fund for Immunisation David Ferreira, MD, Innovative Finance Paolo Sison, Director, Innovative Finance Agenda

More information

VALUE TO A SPONSOR PARTNER OR DONOR. Dementia Alliance International

VALUE TO A SPONSOR PARTNER OR DONOR. Dementia Alliance International VALUE TO A SPONSOR PARTNER OR DONOR Dementia Alliance International ABOUT DEMENTIA ALLIANCE INTERNATIONAL (DAI) Dementia Alliance International (DAI) is a registered non-profit organisation and a US Corporation

More information

Our 2011 achievements

Our 2011 achievements Our 2011 achievements 2011, our centenary year, was a watershed in our history. We spent 106 million on services for people affected by cancer our highest figure ever. We supported a total of 4.9 million

More information

Pfizer Healthcare Ireland Patient Association Funding Disclosure 2013

Pfizer Healthcare Ireland Patient Association Funding Disclosure 2013 Pfizer Healthcare Ireland Patient Association Funding Disclosure 2013 Pfizer has implemented a new standard approach for full transparency of grants to patient organisations. With this new commitment,

More information

Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta. Learning objectives

Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta. Learning objectives Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta Justine Fitzpatrick 19 th February 2008- Public Health WORKS Speaker Series Learning

More information

STRATEGIC PLAN 2014 to 2017

STRATEGIC PLAN 2014 to 2017 STRATEGIC PLAN 2014 to 2017 September 2014 1 P a g e KHNZ s STRATEGIC PLAN Contents Page 1. Introduction to the Strategic Plan 3 2. About Kidney Health New Zealand 4 3. The Challenges 6 4. Strategic Context

More information

Application Pack. Endometriosis UK Trustees

Application Pack. Endometriosis UK Trustees Application Pack Endometriosis UK Trustees RECRUITING FOR THREE NEW TRUSTEES WITH A BACKGROUND IN: MARKETING AND COMMUNICATIONS CHARITY INCOME GENERATION AND FUNDRAISING HEALTH POLICY Contents 1. Welcome

More information

JOB DESCRIPTION JOB TITLE: STATUS: HOURS: SALARY: HOLIDAY: LOCATION: REPORTS TO: DIRECT REPORTS: KEY INTERNAL RELATIONSHIPS:

JOB DESCRIPTION JOB TITLE: STATUS: HOURS: SALARY: HOLIDAY: LOCATION: REPORTS TO: DIRECT REPORTS: KEY INTERNAL RELATIONSHIPS: JOB DESCRIPTION JOB TITLE: Senior Policy and Public Affairs Officer STATUS: Permanent contract HOURS: 37.5 hours per week 9:00am 5:30pm (JDRF operates a flexible working hours policy) SALARY: 29,800 per

More information

HEALTH AND SPORT COMMITTEE AGENDA. 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018

HEALTH AND SPORT COMMITTEE AGENDA. 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018 HS/S5/18/14/A HEALTH AND SPORT COMMITTEE AGENDA 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018 The Committee will meet at 10.00 am in the James Clerk Maxwell Room (CR4). 1. Scottish Health Council Review:

More information

Role Profile. Communications and Engagement Campaigns and Public Affairs Manager. Job title(s) of direct reports. Our three values

Role Profile. Communications and Engagement Campaigns and Public Affairs Manager. Job title(s) of direct reports. Our three values Role Profile We re Breast Cancer Now, the UK s largest breast cancer charity and we re dedicated to funding research into this devastating disease. We believe that if we all act now, by 2050, everyone

More information

Ensuring effective commissioning of cancer services: A survey of GPs

Ensuring effective commissioning of cancer services: A survey of GPs Ensuring effective commissioning of cancer services: A survey of GPs Effective commissioning of cancer services will be essential if outcomes for cancer patients are to continue improving across the country.

More information

An introduction to Arrhythmia Alliance - Australia ABN

An introduction to Arrhythmia Alliance - Australia ABN An introduction to Arrhythmia Alliance - Australia Trudie Lobban, MBE What is a heart rhythm disorder? A heart rhythm disorder (cardiac arrhythmia) is the medical term for an irregular heartbeat or abnormal

More information

Networking for success: A burning platform in Berkshire West

Networking for success: A burning platform in Berkshire West SERVICE REDESIGN CASE STUDY 1: NOVEMBER 2014 Networking for success: A burning platform in Berkshire West SUMMARY In 2012, four federated CCGs set up a network to redesign diabetes services in Berkshire

More information

Pfizer Healthcare Ireland Patient Association Funding Disclosure 2017

Pfizer Healthcare Ireland Patient Association Funding Disclosure 2017 Pfizer Healthcare Ireland Patient Association Funding Disclosure 2017 Pfizer has implemented a standard approach for full transparency of grants and donations to patient organisations. With this commitment,

More information

Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology )

Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology ) Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology ) Table of contents Preamble... 0 1. General Summary... 1 2. Terminology and Definitions... 2 3. Change log... 8 Preamble Novo

More information

The Future of the Peer Review Programme

The Future of the Peer Review Programme The Future of the Peer Review Programme The future of the programme has been in some considerable doubt. However thanks to the support of: Sean Duffy National Clinical Lead for Cancer, James Palmer Clinical

More information

COBCOE MEMBERSHIP INFORMATION PACK

COBCOE MEMBERSHIP INFORMATION PACK THE COUNCIL OF BRITISH CHAMBERS OF COMMERCE IN EUROPE COBCOE MEMBERSHIP INFORMATION PACK Join the international chamber community Help your members reach new markets Access new opportunities and support

More information

2016 NYC Hep B Coalition Work Plan

2016 NYC Hep B Coalition Work Plan The NYC Hepatitis B Coalition mission is to coordinate efforts to prevent, manage and reduce hepatitis B among all residents of New York City. The coalition seeks to foster an inclusive collaboration among

More information

38-43k depending upon experience, plus London weighting and contributory pension scheme. Willcox House, Borough High Street, London SE1 1LB

38-43k depending upon experience, plus London weighting and contributory pension scheme. Willcox House, Borough High Street, London SE1 1LB JOB DESCRIPTION Head of Support Services Reporting to: Salary: Location: Director of Services 38-43k depending upon experience, plus London weighting and contributory pension scheme Willcox House, 140-148

More information

Activity Report April 2012 to March 2013

Activity Report April 2012 to March 2013 North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2012 to March 2013 Professor Roy Rampling Emeritus Professor

More information

Terms of Reference: PR and Media Officer ENDAIDS2030 Festival

Terms of Reference: PR and Media Officer ENDAIDS2030 Festival Terms of Reference: PR and Media Officer ENDAIDS2030 Festival Date of Contract : for completion by 1 st December 2018 Number of Days: 15 STOPAIDS is looking for an experienced PR and Media Officer to coordinate

More information

Alcohol Health Alliance UK response to the Chief Medical Officer s Alcohol Guidelines Review. March 2016

Alcohol Health Alliance UK response to the Chief Medical Officer s Alcohol Guidelines Review. March 2016 Alcohol Health Alliance UK response to the Chief Medical Officer s Alcohol Guidelines Review. March 2016 The Alcohol Health Alliance UK (AHA UK) welcomes the opportunity to comment on the clarity and practicality

More information

Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre

Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre 1) History of the organisation(s) Founded in 1997 by: Dutch liver

More information

Responsible Business Week 2018: April, 2018 Sponsorship Pack

Responsible Business Week 2018: April, 2018 Sponsorship Pack 23-27 April, 2018 Sponsorship Pack www.bitc.org.uk/rbweek Sponsorship Proposal Every Business Can Make a Difference, Place by Place Responsible Business Week (23-27 April 2018) is an annual awareness campaign

More information

PROMOTING HUMAN ORGAN DONATION AND TRANSPLANTATION IN NORTHERN IRELAND. Consultation Proposals & Response Questionnaire

PROMOTING HUMAN ORGAN DONATION AND TRANSPLANTATION IN NORTHERN IRELAND. Consultation Proposals & Response Questionnaire PROMOTING HUMAN ORGAN DONATION AND TRANSPLANTATION IN NORTHERN IRELAND Consultation Proposals & Response Questionnaire 11 December 2017 12 March 2018 Consultation Proposals Policy Objectives and Key Commitments

More information

The audit is managed by the Royal College of Psychiatrists in partnership with:

The audit is managed by the Royal College of Psychiatrists in partnership with: Background The National Audit of Dementia (NAD) care in general hospitals is commissioned by the Healthcare Quality Improvement Partnership on behalf of NHS England and the Welsh Government, as part of

More information

Local Action Plan SOUTH WEST

Local Action Plan SOUTH WEST 1 Local Action Plan -2019 SOUTH WEST Background The south west area covers Cornwall, Devon, Somerset, Wiltshire, Gloucestershire, Bristol and Bath Map As of 31 st December 2016 there were around 270 people

More information

Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008

Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008 Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe Lucca, Italy 13-14 March 2008 Objectives Review activities, role, rationale and impact

More information

ELECTIONS APPLICATION FORM WPHNA Executive Committee

ELECTIONS APPLICATION FORM WPHNA Executive Committee ELECTIONS 2017 APPLICATION FORM WPHNA Executive Committee This is the Application form for the 2017 WPHNA Elections. All queries about positions, the election process, or any other relevant matter, should

More information

Engaging to Improve Access Zack Pemberton-Whiteley. Head of Campaigns and Advocacy Leukaemia CARE, UK

Engaging to Improve Access Zack Pemberton-Whiteley. Head of Campaigns and Advocacy Leukaemia CARE, UK Engaging to Improve Access Zack Pemberton-Whiteley Head of Campaigns and Advocacy Leukaemia CARE, UK zackpw@leukaemiacare.org.uk 01905 755977 Introduction Remember to tailor your approach to what is appropriate

More information

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership Invitation to Comment This new draft strategy has been developed to ensure that the Forum continues to thrive, that we meet the needs of the community over the next five years, and that by acting together

More information

British Society for Immunology. Corporate Membership Packages

British Society for Immunology. Corporate Membership Packages Corporate Membership Packages Become a corporate member and support the immunology community Activities that our corporate members support Our members come from 56 countries around the world. Immunology

More information

Volunteering in NHSScotland Developing and Sustaining Volunteering in NHSScotland

Volunteering in NHSScotland Developing and Sustaining Volunteering in NHSScotland NG11-07 ing in NHSScotland Developing and Sustaining ing in NHSScotland Outcomes The National Group for ing in NHS Scotland agreed the outcomes below which formed the basis of the programme to develop

More information

4. Project Inform does receive restricted donations from corporations, non-profits, foundations, and government entities.

4. Project Inform does receive restricted donations from corporations, non-profits, foundations, and government entities. DONATION GUIDELINES As a non-profit organization, Project Inform is able to fulfill its mission and provide services, free of charge, because of its fundraising and outreach efforts. Project Inform receives

More information

EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS

EPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS EPAG UPDATE Lenja Wiehe European Patient Advocacy Groups Manager, EURORDIS Patient Centre & Empowerment European Reference Networks (ERNs) created on founding principles of patient-centred care, patient

More information

British Association for Supported Employment Annual Conference Sponsorship brochure

British Association for Supported Employment Annual Conference Sponsorship brochure British Association for Supported Employment Annual Conference 2017 Sponsorship brochure Brighton Jurys Inn 8-9 November 2017 Principal conference sponsor: The British Association for Supported Employment

More information

Local Action Plan WALES

Local Action Plan WALES 1 Local Action Plan 2017-2019 WALES Background As of 1 st January 2017 there were 230 people known to the Association with MND, 6 MND Association branches and, 14 regularly active Multi- Disciplinary teams

More information

FINAL MAY 2017 Novo Nordisk Scandinavia AB Methodology Note - reporting year 2016 ( Methodology ) Preamble General Summary...

FINAL MAY 2017 Novo Nordisk Scandinavia AB Methodology Note - reporting year 2016 ( Methodology ) Preamble General Summary... Novo Nordisk Scandinavia AB Methodology Note - reporting year 2016 ( Methodology ) Table of contents Preamble... 1 1. General Summary... 2 2. and Definitions... 3 Preamble Novo Nordisk Scandinavia AB (Novo

More information

CORPORATE REPORT Communication strategy

CORPORATE REPORT Communication strategy CORPORATE REPORT Communication Strategy 2014-17 1 Introduction This strategy sets out the Commission s goals and objectives in relation to its communication activities for the next three years. It has

More information

FOOD MATTERS: an update on developments in food, health and homelessness in Scotland

FOOD MATTERS: an update on developments in food, health and homelessness in Scotland FOOD MATTERS: an update on developments in food, health and homelessness in Scotland Edition 3 February 2007 Welcome to the third edition of Food Matters. First and foremost, I would like to thank those

More information

South Lanarkshire Council. Autism Strategy. Action Plan. Update April 2014

South Lanarkshire Council. Autism Strategy. Action Plan. Update April 2014 South Lanarkshire Council Autism Strategy Action Plan Update April 2014 Ten Indicators for current best practice in the provision of effective Autism Spectrum Disorder (ASD) services 1. A local Autism

More information

Prevention Concordat for Better Mental Health An Overview January Julie Daneshyar North East Public Health England Centre

Prevention Concordat for Better Mental Health An Overview January Julie Daneshyar North East Public Health England Centre Prevention Concordat for Better Mental Health An Overview January 2018 Julie Daneshyar North East Public Health England Centre Why was the Prevention Concordat set up? The programme has been set up in

More information

Atrial Fibrillation Collaborative. Thursday 7 May 2015

Atrial Fibrillation Collaborative. Thursday 7 May 2015 Atrial Fibrillation Collaborative Thursday 7 May 2015 Welcome and introductions Peter Carpenter KSS AHSN Nicky Jonas SEC CVD SCN AF Project Support KSS Academic Health Science Network & South East Cardiovascular

More information

Shaping the services you use

Shaping the services you use Shaping the services you use fsdc would like to thank Action for Sick Children Scotland for their help in producing this guide. COVER IMAGE CREDIT: flickr.com/stephanski A guide to parent participation

More information

JOB DESCRIPTION. ImROC Business Manager (Mental Health Network) and Senior. Policy Manager (NHS Clinical Commissioners)

JOB DESCRIPTION. ImROC Business Manager (Mental Health Network) and Senior. Policy Manager (NHS Clinical Commissioners) JOB DESCRIPTION Job Title: Location: Salary: Reports To: Accountable To: Team Administrator London 21,630 (plus London weighting) ImROC Business Manager (Mental Health Network) ImROC Business Manager (Mental

More information

STRATEGIC PLAN

STRATEGIC PLAN STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,

More information

London Association of Directors of Public Health Priorities for Collaboration September 2017 September 2018

London Association of Directors of Public Health Priorities for Collaboration September 2017 September 2018 ADPH London London Association of Directors of Public Health Priorities for Collaboration September 2017 September 2018 Improving and protecting the health of Londoners 1 Table of Contents Welcome 3 About

More information

NHSBT Board September Chief Executive s Board Report

NHSBT Board September Chief Executive s Board Report 16-77 NHSBT Board September 29 2016 Chief Executive s Board Report 1. Status Public 2. Executive Summary This paper summarises key communications activity and highlights other issues of performance and

More information

Diabetes in Pregnancy Network: Scoping survey March 2013

Diabetes in Pregnancy Network: Scoping survey March 2013 Diabetes in Pregnancy Network: Scoping survey March 2013 Diabetes in Pregnancy Network Scoping Survey Aim To inform the development of a National Diabetes in Pregnancy Network Objectives To identify the

More information

Changing Lives Nationwide

Changing Lives Nationwide Changing Lives Nationwide Strategic Plan 2015-2018 1. Introduction 2. Overall themes for 2015-18 3. Vision & principles 4. Strategic planning 5. Operational priorities & activities 6. About OCD & OCD Action

More information

Published December 2015

Published December 2015 Published December 2015 Contents Executive summary 3 1. Introduction The changing story of cancer 6 2. Current state Poor performance 7 Fragmentation and duplication 7 Existing and developing programme

More information

Job information pack Senior Operations Manager - Scotland

Job information pack Senior Operations Manager - Scotland Job information pack Senior Operations Manager - Scotland Thank you for your interest in Pancreatic Cancer UK t is a pleasure to know that you are interested in working with us. Please find enclosed further

More information

Toolkit to Establish an Arrhythmia Alliance National Partner

Toolkit to Establish an Arrhythmia Alliance National Partner Toolkit to Establish an Arrhythmia Alliance National Partner +44 (0) 1789 450787 trudie@heartrhythmcharity.org.uk Index 2 1. Introduction..3 2. National Partners and Affiliates..4 3. The 8 Steps to Start

More information

Herts Sports Partnership Stakeholder Engagement Plan

Herts Sports Partnership Stakeholder Engagement Plan Herts Sports Partnership Stakeholder Engagement Plan Introduction One of the features of the Hertfordshire sports and physical activity landscape, is the strength of partnerships, involving key agencies,

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Consideration of consultation responses on review proposal Review of TA 118 Colorectal cancer (metastatic) - bevacizumab &

More information

Ministry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW

Ministry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW Chapter 1 Section 1.08 Ministry of Health and Long-Term Care Palliative Care Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW # of Status of Actions Recommended Actions

More information

This is supported by more detailed targets and indicators in the Single Outcome Agreement.

This is supported by more detailed targets and indicators in the Single Outcome Agreement. 7. CANCER PLANNING FRAMEWORK 7.1 Analysis of Local Position 7.1.1 The CHP has a key role to play in the delivery of the cancer planning framework. Local planning for cancer services is co-ordinated through

More information

Apixaban for stroke prevention in atrial fibrillation. August 2010

Apixaban for stroke prevention in atrial fibrillation. August 2010 Apixaban for stroke prevention in atrial fibrillation August 2010 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to

More information

BSGE Council Member Declaration of Interests 2017

BSGE Council Member Declaration of Interests 2017 BSGE Council Member Declaration of Interests 2017 Name Kirana Arambage BSGE Role Chair- Awards & Bursaries DoI signed on 30 Aug 2017 Dominic Byrne President 18 Aug 2017 Any office or position held in NHS

More information

From Better to Best: Improving the availability of organs for transplant

From Better to Best: Improving the availability of organs for transplant From Better to Best: Improving the availability of organs for transplant Elisabeth Buggins CBE Strategy Oversight Group Chair Presentation outline Progress 2004-2014 Strategy and work underway Outcomes

More information

MRC Network of Hubs for Trials Methodology Research Gordon Murray, University of Edinburgh

MRC Network of Hubs for Trials Methodology Research Gordon Murray, University of Edinburgh Edinburgh All All Ireland Ireland North West Midlands MRC-CTSU - CTSU MRC MRC- - BSU ConDuCT MRC- - CTU MRC Network of Hubs for Trials Methodology Research Gordon Murray, University of Edinburgh www.methodologyhubs.mrc.ac.uk

More information

Heritage Trust Network

Heritage Trust Network Registered Charity No. 1167662 Company No. 9943640 Heritage Trust Network Benjamin Parker, Development Officer (England) Heritage Trust Network HERITAGE TRUST NETWORK is the umbrella body for any not-for-profit

More information

Item 4. Sexual Health and Blood Borne Virus Strategy Strategy for Sexual Health and Blood Borne Viruses. Background

Item 4. Sexual Health and Blood Borne Virus Strategy Strategy for Sexual Health and Blood Borne Viruses. Background Item 4 Strategy for Sexual Health and Blood Borne Viruses Background 1. In August 2011 the Scottish Government launched a joint Sexual Health and Blood Borne Virus Framework. This brought four policy areas

More information

RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS

RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS Stakeholder Group Interest in RD-Action Dissemination purpose Channels of Dissemination (WHO) (WHY) (WHY) (HOW) Partners of RD-Action & members

More information

Evaluation report for The Advocacy Project. Executive Summary

Evaluation report for The Advocacy Project. Executive Summary Evaluation report for The Advocacy Project Executive Summary 2015 Acknowledgements We were privileged to have had this opportunity to spend time at The Advocacy Project and to learn more about the valuable

More information